AL
DRNA

AJO LP’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

AJO LP’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-28,307
Closed -$509K – 696
2020
Q3 		$509K Sell
28,307
-65,026
-70% -$1.35M 0.01% 531
2020
Q2 		$2.37M Buy
93,333
+83,845
+884% +$1.81M 0.02% 360
2020
Q1 		$174K Buy
+9,488
New +$184K ﹤0.01% 576

Other funds holding DRNA

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AJO LP's DRNA Position: Q4 2020 in Review

AJO LP sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2020, closing a stake of 28,307 shares — an estimated $509K sold.

AJO LP first reported a position in DRNA in Q1 2020 and held it in 3 quarters. The position peaked at $2.37M in Q2 2020. 173 funds tracked by Wall St. Rank hold DRNA as of Q4 2020.

  • AJO LP reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • AJO LP sold 28,307 Dicerna Pharmaceuticals, Inc. shares in Q4 2020, an estimated $509K.
  • AJO LP first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2020 and held it in 3 quarters.
  • AJO LP's Dicerna Pharmaceuticals, Inc. position peaked at $2.37M in Q2 2020.
  • 173 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2020.

Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.